Next-generation sequencing identifies the presence of protein phosphatase 1D, PPM1D, as a potential biomarker of resistance to PARP inhibition in metastatic castration-resistant prostate cancer.
Vellky JE et al.
American Journal of Clinical and Experimental Urology, 2025